Kimberly Schlapman, a member of Little Massive City, has joined forces with pharmaceutical analysis firm AbbVie to lift consciousness about Parkinson’s illness. This partnership is a part of their Altering the Tune of Parkinson’s Illness marketing campaign, which holds a particular significance for Schlapman. As she shared with Style of Nation Nights’ Evan Paul, her involvement in advocating for Parkinson’s consciousness stems from her mom Barbara’s expertise with the illness, which has been progressing for over 20 years.
Schlapman’s household has made important changes to look after her mom, together with relocating to her childhood hometown in South Carolina to be nearer to Barbara. Though they nonetheless keep a presence in Nashville, the place Little Massive City relies, their major focus has shifted to supporting Barbara as her situation turns into more and more debilitating.
“I am so keen about all the things that goes together with Parkinson’s illness. It is all about empowering folks that dwell with Parkinson’s, or the folks that deal with them,” Schlapman says. Her mom’s willpower to combat the illness is admirable, as Schlapman notes, “She’s combating with all the things she has, she’s combating this illness.”
Having a supportive advocate like Schlapman could make a big distinction for these affected by Parkinson’s. The illness is a progressive neurodegenerative dysfunction characterised by the gradual dying of sure mind cells, resulting in signs comparable to tremors, motion slowness, stiffness, impaired stability, and adjustments in temper, sleep, and cognitive talents. As of 2025, roughly 1.1 million individuals within the U.S. reside with Parkinson’s, and this quantity is predicted to extend by 2030.
Schlapman’s efforts to lift consciousness and assist for Parkinson’s illness are essential, particularly contemplating the rising variety of individuals affected by the situation. Her private connection to the illness and her dedication to empowering these impacted by it make her a useful advocate for the Parkinson’s group.
